The latest report by IMARC Group, titled “Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound Guided Biopsy, Stereotactic Guided Biopsy, MRI Guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Region 2025-2033“, The global biopsy devices market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033.
Biopsy instruments are essential in the realm of medical diagnostics and healthcare. These specialized devices are employed by medical professionals to obtain tissue samples from different areas of the human body for subsequent examination. Biopsy procedures are vital for diagnosing and evaluating the existence of diseases, including cancer, infections, and various other medical issues. These instruments are engineered to minimize invasiveness while ensuring precise tissue sampling, thereby making them a crucial element of the healthcare system.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Biopsy Devices Market Trends and Drivers:
Among the foremost factors propelling the market is the increasing burden of cancer and chronic diseases throughout the world. Consequently, as cancer incidence rises tremendously, the incidence in demand for biopsy procedures and devices has started increasing. Healthcare providers are depending on these biopsy devices to retrieve tissue samples that are critically needed to confirm the diagnosis of cancer, stage it, and plan treatment accordingly. Hence the growing prevalence and considerable demand for these kinds of devices jointly contribute to market growth over the years to come. Another important trend in the global biopsy devices market is the continuous innovation and advancement in biopsy device technology. Manufacturers are now trying to make devices that are much more efficient and easy to use. This includes features like real-time imaging and other guidance systems, which improve the precision and accuracy of the biopsy process. The emergence of minimally invasive techniques for performing biopsies, including fine-needle aspiration and core needle biopsy, has gained acceptance. Less discomfort for patients, less recovery time, and considerably lower healthcare costs for the hospitals or clinics that provide the services will lead to more business with the sale of biopsy devices. In addition, government initiatives with regulatory approvals go a long way in strengthening the Global biopsy devices market. Governments and regulatory bodies are aiming at fast-tracking the acceptance for new biopsy devices while ensuring the safety and efficacy of such devices. Such regulatory support provides manufacturers with a streamlined pathway to entry, thus ensuring competition and innovation in the industry and further propelling the market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound Guided Biopsy
- Stereotactic Guided Biopsy
- MRI Guided Biopsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Argon Medical Devices
- Becton Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- CONMED Corporation
- Cook Group Incorporated
- Hologic Inc.
- INRAD Inc.
- Medtronic plc
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.